Partner News | Published: Wednesday, May 21, 2025
Octagos, the industry leader in AI-powered cardiac remote monitoring, announced the launch of OctaLink, a new clinical companion mobile app delivering the full power of the Octagos platform in the palm of your hands.
Built on Octagos' commitment to clinical precision and workflow efficiency, OctaLink provides secure, instant access to real-time alerts and critical tasks from any location. The app brings enterprise-level remote monitoring to the exact moment care decisions happen.
"As a practicing electrophysiologist, I know how much speed and clarity matter in patient care," said Dr. Shanti Bansal, CEO of Octagos. "OctaLink was built to give clinicians immediate access to the data they need, the moment they need it. Whether you're in the clinic or on-call, you can act with confidence and precision. That's how we raise the standard of care."
OctaLink is a purpose-built mobile application supporting clinicians' mobility without sacrificing functionality. The streamlined mobile interface allows care teams to review, triage, and respond without delay.
"Last weekend, I got an urgent alert about a patient with arrhythmias. With OctaLink, I reviewed the critical data and made a decision, all from my phone," said Dr. David Bello, MD, Cardiac Electrophysiology at The Cardiovascular Center of Florida. "I didn't have to rush back to the clinic. The ability to manage critical cases remotely, especially during on-call weekends, has changed our remote monitoring workflow and response times."
Dr. Bello's experience illustrates how OctaLink delivers more than convenience. It puts clinical intelligence to work by combining real-time data access with a customizable workflow, enabling fast and secure action when it matters most.
OctaLink is now available for download on iOS and Android platforms, exclusively for Octagos customers. Clinicians can easily get started by visiting this page to download the app and gain immediate access to critical cardiac monitoring tools.
By continuing to use our site, you agree to our Cookie Policy, Privacy Policy and Terms of Use.